IDXX | tickerfilter.com

Fundamental analysis

56%

Profitability 81%

Dept financing 25%

Liquidity 5%

Performance 52%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0.64%

1 Month

-11.75%

3 Months

-16.13%

6 Months

-9.39%

1 Year

34.24%

2 Year

5.54%

Key data

Stock price

$561.89

P/E Ratio

50.99

DAY RANGE

$548.51 - $566.57

EPS

$13.17

52 WEEK RANGE

$356.14 - $769.98

52 WEEK CHANGE

$31.82

MARKET CAP

54.022 B

YIELD

N/A

SHARES OUTSTANDING

79.624 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

08-04-2025

BETA

0.89

PUBLIC FLOAT

AVERAGE 10 VOLUME

$478,526

AVERAGE 30 VOLUME

$520,052

Company detail

CEO: Jonathan J. Mazelsky
Region: US
Website: idexx.com
Employees: 10,800
IPO year: 1991

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Sector: Manufacturing

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for companion animal veterinary, livestock and poultry, dairy, and water testing markets. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides veterinary diagnostic products, including instruments, consumables, and rapid assay test kits.

IDXX - IDEXX LABORATORIES INC /DE